Skip to content

Clinical trials

Phase 2 Inflammation trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20114
20124
20131
20151
20181
20192
20203
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated6
Active, not recruiting3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S7
AstraZeneca4
Amgen2
Abcentra1
GlaxoSmithKline1
Hoffmann-La Roche1
InflaRx GmbH1
Inmune Bio, Inc.1
Janssen Research & Development, LLC1
Medical University of Lublin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation23
Crohn Disease6
Arthritis, Rheumatoid5
Bronchitis, Chronic2
Inflammatory Bowel Diseases2
Pulmonary Disease, Chronic Obstructive2
Abdominal Pain1
Acute Coronary Syndrome1
Alzheimer Disease1
Asthma1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.